Impact of the Health Insurance Coverage Policy on Oral Anticoagulant Prescription among Patients with Atrial Fibrillation in Korea from 2014 to 2016

Journal of Korean Medical Science
Young-Jin KoByung-Joo Park

Abstract

To evaluate oral anticoagulant (OAC) utilization in patients with atrial fibrillation after the changes in the health insurance coverage policy in July 2015. We used the Health Insurance Review and Assessment Service-National Patient Samples (HIRA-NPS) between 2014 and 2016. The HIRA-NPS, including approximately 1.4 million individuals, is a stratified random sample of 3% of the entire Korean population using 16 age groups and 2 sex groups. The HIRA-NPS comprises personal and medical information such as surgical or medical treatment provided, diagnoses, age, sex, region of medical institution, and clinician characteristics. The studied drugs included non-vitamin K antagonist OACs (NOACs) such as apixaban, dabigatran, edoxaban, and rivaroxaban, and were compared with warfarin. We analyzed drug utilization pattern under three aspects: person, time, and place. The number of patients with atrial fibrillation who were prescribed OACs was 3,114, 3,954, and 4,828; and the proportions of prescribed NOACs to total OACs were 5.1%, 36.2%, and 60.8% in 2014, 2015, and 2016, respectively. The growth rate of OACs prescription increased from 61.4 patients/quarter before June 2015 to 147.7 patients/quarter thereafter. These changes were predom...Continue Reading

References

Aug 1, 1991·Stroke; a Journal of Cerebral Circulation·P A WolfW B Kannel
Aug 14, 2002·Journal of Clinical Pharmacy and Therapeutics·A K WagnerD Ross-Degnan
Dec 12, 2012·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Thomas WilkeGünter Breithardt
May 3, 2014·Journal of the American Geriatrics Society·Partha SardarGregory Y H Lip
Aug 13, 2014·Nature Reviews. Cardiology·Faisal RahmanEmelia J Benjamin
Oct 21, 2015·Clinical Therapeutics·Jeffrey I WeitzJohn A Cairns
Feb 17, 2017·JAMA : the Journal of the American Medical Association·Tatjana S Potpara, Gregory Y H Lip
Jul 25, 2017·European Journal of Clinical Pharmacology·Lars J KjerpesethEva Skovlund
Oct 5, 2017·Stroke; a Journal of Cerebral Circulation·Myung-Jin ChaGregory Y H Lip

❮ Previous
Next ❯

Citations

Mar 13, 2020·Circulation. Cardiovascular Quality and Outcomes·So-Ryoung LeeGregory Y H Lip
Sep 1, 2019·Journal of Thrombosis and Thrombolysis·Z B Wojszel, A Kasiukiewicz
Sep 16, 2019·International Journal of Clinical Pharmacy·Hye-Yoon SongSeungJin Bae
May 21, 2019·Current Sleep Medicine Reports·Abdelnaby Khalyfa, David Gozal
Jun 20, 2020·Therapeutic Innovation & Regulatory Science·IlYoung Cho
Dec 30, 2020·Journal of the American Heart Association·Keon-Joo LeeUNKNOWN CRCS‐K Registry Investigators
Jan 9, 2021·Stroke; a Journal of Cerebral Circulation·Soonil KwonGregory Y H Lip
Mar 31, 2021·Journal of the Chinese Medical Association : JCMA·Chun-Wei LeeHung-I Yeh
Oct 1, 2021·Journal of Clinical Pharmacy and Therapeutics·Xiaojiao GongPan Chen
Dec 10, 2021·Journal of Wound Care·Kyu Sang Cho, Jang Hyun Lee

❮ Previous
Next ❯

Software Mentioned

SAS
QGIS

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.